BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 30080683)

  • 1. Challenges of TB and HIV co-treatment: updates and insights.
    Tornheim JA; Dooley KE
    Curr Opin HIV AIDS; 2018 Nov; 13(6):486-491. PubMed ID: 30080683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment optimization in patients co-infected with HIV and Mycobacterium tuberculosis infections: focus on drug-drug interactions with rifamycins.
    Regazzi M; Carvalho AC; Villani P; Matteelli A
    Clin Pharmacokinet; 2014 Jun; 53(6):489-507. PubMed ID: 24777631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Effect of Early Initiation of Antiretroviral Therapy in TB/HIV-Coinfected Patients: A Systematic Review and Meta-Analysis.
    Abay SM; Deribe K; Reda AA; Biadgilign S; Datiko D; Assefa T; Todd M; Deribew A
    J Int Assoc Provid AIDS Care; 2015; 14(6):560-70. PubMed ID: 26289343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New management approaches to tuberculosis in people living with HIV.
    Mhango DV; Mzinza DT; Jambo KC; Mwandumba HC
    Curr Opin Infect Dis; 2021 Feb; 34(1):25-33. PubMed ID: 33315751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The cursed duet today: Tuberculosis and HIV-coinfection.
    Tiberi S; Carvalho AC; Sulis G; Vaghela D; Rendon A; Mello FC; Rahman A; Matin N; Zumla A; Pontali E
    Presse Med; 2017 Mar; 46(2 Pt 2):e23-e39. PubMed ID: 28256380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV-associated pediatric tuberculosis: prevention, diagnosis and treatment.
    Kay A; Garcia-Prats AJ; Mandalakas AM
    Curr Opin HIV AIDS; 2018 Nov; 13(6):501-506. PubMed ID: 30286040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of drug-resistant tuberculosis among people living with HIV.
    Hurtado RM; Meressa D; Goldfeld AE
    Curr Opin HIV AIDS; 2018 Nov; 13(6):478-485. PubMed ID: 30286039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tuberculosis: burning issues: multidrug resistance and HIV-coinfection.
    Janbaz KH; Qadir MI; Ahmad B; Sarwar A; Yaqoob N; Masood MI
    Crit Rev Microbiol; 2012 Nov; 38(4):267-75. PubMed ID: 22421086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV infection and multidrug-resistant tuberculosis: the perfect storm.
    Wells CD; Cegielski JP; Nelson LJ; Laserson KF; Holtz TH; Finlay A; Castro KG; Weyer K
    J Infect Dis; 2007 Aug; 196 Suppl 1():S86-107. PubMed ID: 17624830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Demanding an end to tuberculosis: treatment of tuberculosis infection among persons living with and without HIV.
    Fargher J; Reuter A; Furin J
    Curr Opin HIV AIDS; 2019 Jan; 14(1):21-27. PubMed ID: 30407203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preventive therapy for HIV-associated tuberculosis.
    Durovni B; Cavalcante S
    Curr Opin HIV AIDS; 2018 Nov; 13(6):507-511. PubMed ID: 30286041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnosis and management of TB in children: an update.
    Marquez L; Starke JR
    Expert Rev Anti Infect Ther; 2011 Dec; 9(12):1157-68. PubMed ID: 22114966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current trends and intricacies in the management of HIV-associated pulmonary tuberculosis.
    Gopalan N; Chandrasekaran P; Swaminathan S; Tripathy S
    AIDS Res Ther; 2016; 13():34. PubMed ID: 27708678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Use of Therapeutic Drug Monitoring in Complex Antituberculous and Antiretroviral Drug Dosing in HIV/Tuberculosis-Coinfected Patients.
    Newman M; Foisy MM; Ahmed RA
    J Int Assoc Provid AIDS Care; 2015; 14(4):295-9. PubMed ID: 25425639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TB-HIV co-infection among pregnant women in Karnataka, South India: A case series.
    Suresh S; Sharath BN; Anita S; Lalitha R; Prasad TJ; Rewari BB
    J Infect Public Health; 2016; 9(4):465-70. PubMed ID: 26711476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Timing of antiretroviral therapy for HIV in the setting of TB treatment.
    Piggott DA; Karakousis PC
    Clin Dev Immunol; 2011; 2011():103917. PubMed ID: 21234380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Managing TB in the 21st century: existing and novel drug therapies.
    Guy ES; Mallampalli A
    Ther Adv Respir Dis; 2008 Dec; 2(6):401-8. PubMed ID: 19124385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. State-of-the-Art Review of HIV-TB Coinfection in Special Populations.
    Weld ED; Dooley KE
    Clin Pharmacol Ther; 2018 Dec; 104(6):1098-1109. PubMed ID: 30137652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of 2-hydroxy-1-naphthaldehyde isonicotinoyl hydrazone as a novel inhibitor of methionine aminopeptidases from Mycobacterium tuberculosis.
    John SF; Aniemeke E; Ha NP; Chong CR; Gu P; Zhou J; Zhang Y; Graviss EA; Liu JO; Olaleye OA
    Tuberculosis (Edinb); 2016 Dec; 101S():S73-S77. PubMed ID: 27856197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.